PMC10421579_01
Three-dimensional (3D) angiotomography image showing bilateral sciatic artery aneurysms.
jvb-22-e20220064-g01-en.jpg
PMC10421579_01_jvb-22-e20220064-g01-en.jpg
gf0100
Later, angiotomography (angioCT) was performed to investigate the emboligenic agent, detecting complete persistent sciatic arteries with fusiform aneurysmal degeneration bilaterally (Figure 1).
Three-dimensional (3D) angiotomography control image 30 days after repair of bilateral sciatic artery aneurysms (coronal plane). Patent stents free from endoleaks.
jvb-22-e20220064-g02-en.jpg
PMC10421579_01_jvb-22-e20220064-g02-en.jpg
gf0200
After 30 days, control angioCT was performed, demonstrating patent stents free from endoleaks (Figures 2 and 3).
Three-dimensional (3D) angiotomography control image 30 days after repair of bilateral sciatic artery aneurysms (sagittal plane).
jvb-22-e20220064-g03-en.jpg
PMC10421579_01_jvb-22-e20220064-g03-en.jpg
gf0300
After 30 days, control angioCT was performed, demonstrating patent stents free from endoleaks (Figures 2 and 3).